Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)

Fig. 6

Tumor delivery of αCD20-armed liposomes in Raji-bearing SCID mice. a αCD20/Lipo-DiD or αDNS/Lipo-DiD were intravenously injected into SCID mice bearing CD20+ tumors (left flank). The fluorescence intensity of DiD was detected at 24 h, 48 h, and 72 h after injection by IVIS. b Total radiant efficiency of αCD20/Lipo-DiD (red) or αDNS/Lipo-DiD (blue) in CD20+ tumors and c the average radiant efficiency of the collected organs and tumors at 72 h were quantified (n = 3). Bars, SEM. **P < 0.01. *P < 0.05; n.s. not significant

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us